Health Care Innovation
Commentary
Biden Is Medical Innovation’s Executioner
President Joe Biden just declared war on medical science — and has undermined his “Cancer Moonshot.” That’s the only way to interpret the administration’s announcement last week arrogating the power to seize patents for medicines and other technologies developed with taxpayer funds on the grounds that they’re too expensive. The president claims ...
Blog
Read how Biden plan would hurt medical innovation
The Biden Administration Abuses Inflation to Attack Medical Innovation
It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Commentary
Will Trump’s Hospital Price Transparency Rule Resurge?
One of President Donald J. Trump’s greatest health-policy coups during his term in office came in 2019. His executive order directed hospitals to disclose the prices of a range of services and treatments. The logic behind the order was straightforward. In order for healthcare markets to function efficiently, patients need ready access ...
Commentary
The Federal Trade Commission’s Assault On Growth
The FTC’s mission is to protect consumers by ensuring that markets are competitive, not to protect competitors. Presumably, the Commissioners imagine that the theoretical harm to competitors will somehow make consumers worse off, but if this sounds far-fetched, this is precisely what an FTC administrative judge concluded when hearing the ...
Commentary
Drug price controls hurt patients
Costly Imported Medicines Leave Patients Vulnerable
Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Commentary
Government Regulation Threatens Life-Saving Innovation
Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.
New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Commentary
Cancer Patients Need Private Innovation, Not Gov’t Meddling
President Joe Biden just announced a new effort that he hopes will spur the development of better, more precise cancer surgery technologies. The program is part of his administration’s “Cancer Moonshot,” which aims to halve cancer death rates in the United States by 2047. Ironically, one of the biggest obstacles to achieving ...
Commentary
Read the latest on the nation's doctor shortage
Fixing the doctor shortage requires less government, not more
Congress is looking to narrow our nation’s doctor shortage. After introducing legislation that would reform our primary care system, Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders (I-VT) said last month , “Tens of millions of Americans live in communities where they cannot find a doctor while others have to wait months to be ...
Commentary
Greater Immigration Can Alleviate Troubling Skilled Nurse Shortage
Immigration, always a strength for the U.S. economy, has the potential to fill a dangerous and growing labor shortage of skilled nurses. According to nurse.org’s 2023 State of Nursing report, “91% of nurses believe the nursing shortage is getting worse, and 79% report that their units are inadequately staffed.” And it’s not just ...
Commentary
A bipartisan way to improve health coverage, help small businesses
The House of Representatives recently passed a healthcare reform bill along party lines. All 220 Republicans who were present voted “aye,” while all 209 Democrats sounded a unanimous “nay.” Judging by that roll call, you’d think the bill — the CHOICE Arrangement Act — was full of partisan measures. But ...
Biden Is Medical Innovation’s Executioner
President Joe Biden just declared war on medical science — and has undermined his “Cancer Moonshot.” That’s the only way to interpret the administration’s announcement last week arrogating the power to seize patents for medicines and other technologies developed with taxpayer funds on the grounds that they’re too expensive. The president claims ...
Read how Biden plan would hurt medical innovation
The Biden Administration Abuses Inflation to Attack Medical Innovation
It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Will Trump’s Hospital Price Transparency Rule Resurge?
One of President Donald J. Trump’s greatest health-policy coups during his term in office came in 2019. His executive order directed hospitals to disclose the prices of a range of services and treatments. The logic behind the order was straightforward. In order for healthcare markets to function efficiently, patients need ready access ...
The Federal Trade Commission’s Assault On Growth
The FTC’s mission is to protect consumers by ensuring that markets are competitive, not to protect competitors. Presumably, the Commissioners imagine that the theoretical harm to competitors will somehow make consumers worse off, but if this sounds far-fetched, this is precisely what an FTC administrative judge concluded when hearing the ...
Drug price controls hurt patients
Costly Imported Medicines Leave Patients Vulnerable
Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Government Regulation Threatens Life-Saving Innovation
Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.
New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Cancer Patients Need Private Innovation, Not Gov’t Meddling
President Joe Biden just announced a new effort that he hopes will spur the development of better, more precise cancer surgery technologies. The program is part of his administration’s “Cancer Moonshot,” which aims to halve cancer death rates in the United States by 2047. Ironically, one of the biggest obstacles to achieving ...
Read the latest on the nation's doctor shortage
Fixing the doctor shortage requires less government, not more
Congress is looking to narrow our nation’s doctor shortage. After introducing legislation that would reform our primary care system, Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders (I-VT) said last month , “Tens of millions of Americans live in communities where they cannot find a doctor while others have to wait months to be ...
Greater Immigration Can Alleviate Troubling Skilled Nurse Shortage
Immigration, always a strength for the U.S. economy, has the potential to fill a dangerous and growing labor shortage of skilled nurses. According to nurse.org’s 2023 State of Nursing report, “91% of nurses believe the nursing shortage is getting worse, and 79% report that their units are inadequately staffed.” And it’s not just ...
A bipartisan way to improve health coverage, help small businesses
The House of Representatives recently passed a healthcare reform bill along party lines. All 220 Republicans who were present voted “aye,” while all 209 Democrats sounded a unanimous “nay.” Judging by that roll call, you’d think the bill — the CHOICE Arrangement Act — was full of partisan measures. But ...
